Text Size

Medium and Long Term Outcome of Total Hip Arthroplasty Using Accolade TMZF Femoral Stem

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Stryker Orthopaedics
Information provided by:
Rothman Institute Orthopaedics
ClinicalTrials.gov Identifier:
NCT00951145
First received: July 31, 2009
Last updated: April 8, 2013
Last verified: April 2013
History of Changes
  Purpose

This is a retrospective/prospective study evaluating the clinical and radiographic outcome of total hip arthroplasty (THA) performed using Accolade femoral stem in a consecutive group of patients. All patients eligible for inclusion will be identified. The investigators hypothesize that the outcome of THA performed using Accolade femoral stem is equal or superior to historical survivorship of THA using other types of collarless, proximally coated, tapered stems.


Condition
Osteoarthritis of the Hip

Study Type: Observational
Study Design: Observational Model: Case-Only
Official Title: Medium and Long Term Outcome of Total Hip Arthroplasty Using Accolade TMZF Femoral Stem

Resource links provided by NLM:

MedlinePlus related topics: Osteoarthritis
U.S. FDA Resources

Further study details as provided by Rothman Institute Orthopaedics:

Primary Outcome Measures:
  • The outcome of THA performed using Accolade femoral stem is equal or superior to historical survivorship of THA using other types of collarless, proximally coated, tapered stem

Secondary Outcome Measures:
  • Proximally coated tapered stems can be used for patients with various bone types, bone morphology, and underlying diagnosis

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

All patients undergoing THA prior to 1/1/2003 using Accolade femoral stem

Criteria

Inclusion Criteria:

  1. All patients undergoing THA prior to 1/1/2003 using Accolade femoral stem.
  2. Patients with hip fracture undergoing THA will also be included.
  3. Patients willing and able to comply with follow-up requirements and self-evaluations.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00951145

Locations
United States, Pennsylvania
Rothman Institute
Philadelphia, Pennsylvania, United States, 19107
Sponsors and Collaborators
Rothman Institute Orthopaedics
Stryker Orthopaedics
Investigators
Principal Investigator: Parvizi Javad, MD Rothman Institute
Principal Investigator: Hozack William, MD Rothman Institute
  More Information

No publications provided

Responsible Party: Javad Parvizi, MD, FRCS, Rothman Institute
ClinicalTrials.gov Identifier: NCT00951145     History of Changes
Other Study ID Numbers: RIFJPAR 09-01
Study First Received: July 31, 2009
Last Updated: April 8, 2013
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Osteoarthritis
Osteoarthritis, Hip
Arthritis
 Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases

ClinicalTrials.gov processed this record on June 17, 2013